OBJECTIVES: We aimed to asses possible clinically significant differences between C. parapsilosis and other candida species candidemia receiving care in the intensive care unit (ICU) setting. METHODS: The study included 118 adult patients diagnosed as candidemia after admission to the ICU of a university hospital between January 2004 and December 2009. Data about demographic characteristics, underlying diseases, and risk factors for ICU-related candidemia were collected. RESULTS: During the study period, 118 patients with candidemia were identified among 2,853 patients admitted into the ICU. Candidemia was seen in 41.4 cases per 1,000 ICU admissions. The overall incidence of candidemia in ICU patients during the study period was 2.09 per 1,000 hospital admissions. Of the isolates, 18.6% were C. albicans and 81.4% were C. non-albicans. The species most frequently isolated was C. parapsilosis (66.1%, 78/118). The distribution of other Candida spp. was as follows: 15 had C. tropicalis (12.7%) and 3 had C. glabrata (2.5%). By Statistical analysis, when patients with candidemia who had C. parapsilosis were compared with other Candida spp., the following factors were found to be significantly associated with C. parapsilosis fungemia; intravascular catheters (p = 0.008), malignity (p = 0.049) and age (p = 0.039). Relationship was found between C. tropicalis and hematologic malignancies (p = 0.001). CONCLUSIONS: When infections with a high mortality such as candidemia is suspected in critically ill patients, it is important to know local risk factors and epidemiological distributions of causative agents in selection of empirical and effective antifungal treatment.
OBJECTIVES: We aimed to asses possible clinically significant differences between C. parapsilosis and other candida species candidemia receiving care in the intensive care unit (ICU) setting. METHODS: The study included 118 adult patients diagnosed as candidemia after admission to the ICU of a university hospital between January 2004 and December 2009. Data about demographic characteristics, underlying diseases, and risk factors for ICU-related candidemia were collected. RESULTS: During the study period, 118 patients with candidemia were identified among 2,853 patients admitted into the ICU. Candidemia was seen in 41.4 cases per 1,000 ICU admissions. The overall incidence of candidemia in ICUpatients during the study period was 2.09 per 1,000 hospital admissions. Of the isolates, 18.6% were C. albicans and 81.4% were C. non-albicans. The species most frequently isolated was C. parapsilosis (66.1%, 78/118). The distribution of other Candida spp. was as follows: 15 had C. tropicalis (12.7%) and 3 had C. glabrata (2.5%). By Statistical analysis, when patients with candidemia who had C. parapsilosis were compared with other Candida spp., the following factors were found to be significantly associated with C. parapsilosis fungemia; intravascular catheters (p = 0.008), malignity (p = 0.049) and age (p = 0.039). Relationship was found between C. tropicalis and hematologic malignancies (p = 0.001). CONCLUSIONS: When infections with a high mortality such as candidemia is suspected in critically illpatients, it is important to know local risk factors and epidemiological distributions of causative agents in selection of empirical and effective antifungal treatment.
Authors: Kevin W Garey; Milind Rege; Manjunath P Pai; Dana E Mingo; Katie J Suda; Robin S Turpin; David T Bearden Journal: Clin Infect Dis Date: 2006-05-16 Impact factor: 9.079
Authors: C Girmenia; P Martino; F De Bernardis; G Gentile; M Boccanera; M Monaco; G Antonucci; A Cassone Journal: Clin Infect Dis Date: 1996-09 Impact factor: 9.079
Authors: Lucia Garcia San Miguel; Javier Cobo; Enrique Otheo; Aurora Sánchez-Sousa; Victor Abraira; Santiago Moreno Journal: Infect Control Hosp Epidemiol Date: 2005-06 Impact factor: 3.254
Authors: Thomas A Clark; Sally A Slavinski; Juliette Morgan; Timothy Lott; Beth A Arthington-Skaggs; Mary E Brandt; Risa M Webb; Mary Currier; Richard H Flowers; Scott K Fridkin; Rana A Hajjeh Journal: J Clin Microbiol Date: 2004-10 Impact factor: 5.948
Authors: Nikolaos V Sipsas; Russell E Lewis; Jeffrey Tarrand; Ray Hachem; Kenneth V Rolston; Issam I Raad; Dimitrios P Kontoyiannis Journal: Cancer Date: 2009-10-15 Impact factor: 6.860
Authors: M T Montagna; G Caggiano; G Lovero; O De Giglio; C Coretti; T Cuna; R Iatta; M Giglio; L Dalfino; F Bruno; F Puntillo Journal: Infection Date: 2013-03-06 Impact factor: 3.553